In this multicenter, retrospective study utilizing real-world data from Turkey, we evaluated the efficacy and safety of adding anti-EGFR or anti-VEGF therapy to fluorouracil-based treatment in patients with isolated liver metastatic colorectal cancer (mCRC) who underwent conversion surgery. Here, EGFR is linked to digestive system neoplasm.